| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1981031A Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses |
| 06/13/2007 | CN1980894A Compounds and compositions as PPAR modulators. |
| 06/13/2007 | CN1980698A Modulation of immunoglobulin production and atopic disorders |
| 06/13/2007 | CN1980675A Preparation for the treatment cancer |
| 06/13/2007 | CN1980653A Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents |
| 06/13/2007 | CN1980649A Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/13/2007 | CN1980647A Formulation comprising histone deacetylase inhibitor |
| 06/13/2007 | CN1977972A Anti tumour drug oral colon targeting preparation and its preparing method |
| 06/13/2007 | CN1977971A Mutant forms of cholera holotoxin as an adjuvant |
| 06/13/2007 | CN1977842A Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 06/13/2007 | CN1977826A Method for increasing prodrug bioavailability using solid lipid nano granule |
| 06/13/2007 | CN1977779A Vascular stent with drug-eluting |
| 06/13/2007 | CN1321111C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/13/2007 | CN1320925C Long time use compound preparation for treating diabetes |
| 06/13/2007 | CN1320923C Cancer vaccine contg. cancer antigen based on tumor suppressor gene WT1 product and cationic liposomes |
| 06/13/2007 | CN1320886C Use of ainfbutamone and anticonvulsant in preparation of treating obesity drug |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/12/2007 | US7230155 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders |
| 06/12/2007 | US7230131 Hydrophilic mixture; granulation; drying; diet adjuvants |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230073 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 06/12/2007 | US7230032 Calcium blockers to treat proliferative vitreoretinopathy |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7229982 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; for treatment of atheroslerosis |
| 06/12/2007 | US7229979 Delivery of drug coated stent; administered systemically; antiinflammatory and antiproliferative agents |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229822 Melanoma differentation associated gene-5 and vectors and cells containing same |
| 06/12/2007 | US7229818 Encapsulated formulation comprising water-free mixture of probiotic bacteria with monovalent alginate salts; for preserving the life of probiotic bacteria during passage through the stomach, while permitting their release in the intestine, and which has a low water activity and long shelf life |
| 06/12/2007 | US7229773 Screening method for apoptosis-suppressing or-promoting substance |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229621 Method to enhance the immunogenicity of an antigen |
| 06/12/2007 | US7229614 Interferon gamma in the detection and treatment of angiomyolipomas |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | CA2284551C New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders |
| 06/07/2007 | WO2007064945A2 Cancer therapies and pharmaceutical compositions used therein |
| 06/07/2007 | WO2007064755A2 Treatment of xerostomia with a sulfur-containing antioxidant |
| 06/07/2007 | WO2007064586A1 Methods of treating anxiety disorders |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007048027A3 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 06/07/2007 | WO2007043542A9 Antituberculous composition comprising oxazole compounds |
| 06/07/2007 | WO2007038073A3 Mutations and polymorphisms of hdac11 |
| 06/07/2007 | WO2006042100A3 Method for the treatment of polycystic kidney disease |
| 06/07/2007 | US20070129439 Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use |
| 06/07/2007 | US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 06/07/2007 | US20070129386 Multiple sclerosis; hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, immunosuppressant |
| 06/07/2007 | US20070129370 Novel pharmaceutical compositions with increased activity |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129314 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system |
| 06/07/2007 | US20070129291 Genobix agonists and antagonists for use in the treatment of metabolic disorders |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128591 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/07/2007 | US20070128241 Methods, compositions, apparatuses containing tetrameric oxygen |
| 06/07/2007 | US20070128227 Multi-step therapy for injured muscles |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128202 inhibiting growth of cancerous cells using an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 06/07/2007 | US20070128177 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 06/07/2007 | US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 06/07/2007 | US20070128169 Inhibition of gene expression by delivery of polynucleotides to animal cells in vivo |
| 06/07/2007 | US20070128167 Complexing agents for compositions containing inclusion complexes |
| 06/07/2007 | CA2631931A1 Cancer therapies and pharmaceutical compositions used therein |
| 06/06/2007 | EP1793001A2 Yeast screens for agents affecting protein folding |
| 06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
| 06/06/2007 | EP1792927A1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 06/06/2007 | EP1792913A1 Novel secreted and membrane-associated proteins and uses therefor |
| 06/06/2007 | EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 06/06/2007 | EP1792620A1 Medicinal composition containing diabetes remedy |
| 06/06/2007 | EP1792617A1 Treatment of dyskinesia |
| 06/06/2007 | EP1792616A1 Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia |
| 06/06/2007 | EP1792615A1 Method of screening for a visceral pain inhibitor |
| 06/06/2007 | EP1791904A2 Method of treating organophosphorous poisoning |
| 06/06/2007 | EP1791854A2 Methods of treating disorders having a component of mercury toxicity |
| 06/06/2007 | EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/06/2007 | EP1791535A2 Novel tellurium compounds and their use as immunomodulators |
| 06/06/2007 | EP1791423A1 Compositions and methods for the management of hyperproliferative dermatological conditions |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1402034B1 Identification of ses-1 and the uses of the same |
| 06/06/2007 | EP1381431B1 Aromatase inhibition to enhance implantation rate |
| 06/06/2007 | EP1229922B1 Aplidine treatment of cancers |
| 06/06/2007 | EP0862625B1 Methods for modulation of cholesterol transport |
| 06/06/2007 | EP0839039B2 Paroxetine controlled release compositions |
| 06/06/2007 | EP0742723B1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 06/06/2007 | CN1976723A Treatment of infectious diseases |
| 06/06/2007 | CN1976722A 活性物质联合 Active substances combined |
| 06/06/2007 | CN1976679A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1973832A Biodegradable nanometer medicine capsule with CT trace effect and its prepn process |
| 06/06/2007 | CN1973827A Prepn process of superfine inhaled glucocorticoid medicine powder |